IceCure Medical Ltd
ICCM
$0.9201
-$0.0311-3.27%
NASDAQ
06/30/2024 | 03/31/2024 | 12/31/2023 | |||
---|---|---|---|---|---|
Net Income | 14.63% | -20.50% | 25.13% | ||
Total Depreciation and Amortization | -3.53% | 2.41% | 1.22% | ||
Total Amortization of Deferred Charges | -- | -- | -- | ||
Total Other Non-Cash Items | -32.99% | 526.09% | -94.15% | ||
Change in Net Operating Assets | 15.36% | 98.96% | 18.40% | ||
Cash from Operations | 17.15% | -6.70% | 9.97% | ||
Capital Expenditure | 78.57% | 65.43% | -5.19% | ||
Sale of Property, Plant, and Equipment | -- | -- | -- | ||
Cash Acquisitions | -- | -- | -- | ||
Divestitures | -- | -- | -- | ||
Other Investing Activities | -261.27% | -94.34% | 133.15% | ||
Cash from Investing | -271.69% | -94.59% | 135.70% | ||
Total Debt Issued | -- | -- | -- | ||
Total Debt Repaid | -- | -- | -- | ||
Issuance of Common Stock | -33.38% | 4,072.06% | 353.33% | ||
Repurchase of Common Stock | -- | -- | -- | ||
Issuance of Preferred Stock | -- | -- | -- | ||
Repurchase of Preferred Stock | -- | -- | -- | ||
Total Dividends Paid | -- | -- | -- | ||
Other Financing Activities | -- | -- | -- | ||
Cash from Financing | -33.38% | 4,072.06% | 353.33% | ||
Foreign Exchange rate Adjustments | 104.65% | -118.86% | 317.14% | ||
Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
Net Change in Cash | -403.46% | -93.54% | 743.65% | ||